IndiGo Ventures raises Rs 450 cr; invests in startup Jeh Aerospace
, the corporate
venture capital
arm of domestic carrier IndiGo, on Monday announced the first close of its maiden fund at Rs 450 crore.
Besides, the company also announced the first investment in Hyderabad-based aerospace startup
Jeh Aerospace
, without disclosing the amount.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Cardiologist Reveals: The Simple Morning Habit for a Flatter Belly After 50!
Lulutox
Undo
Jeh will deploy the investment to scale its advanced digital manufacturing infrastructure, enhance its AI-driven production optimization and deep supply chain integration platforms, and attract engineering and production talent, it said.
Launched in August last year with approval from SEBI to raise Rs 600 crore, IndiGo Ventures is focused on investing in early-stage startups driving
innovation
in aviation and allied sectors.
The fund targets companies at the pre-Series A to Series B stages, with an emphasis on long-term strategic alignment.
Live Events
This first close and investment (in Jeh Aerospace) marks a significant step in IndiGo's broader innovation agenda' combining operational expertise with
capital
to empower entrepreneurs solving critical challenges in aerospace and related domains, it said.
Founded by industry veterans Vishal Sanghavi and Venkatesh Mudragalla - alumni of Tata's aerospace joint ventures with Boeing, Lockheed Martin, and Sikorsky - Jeh Aerospace combines deep sectoral expertise with sharp operational execution.
Within its first year of operations, Jeh Aerospace has scaled to a 100-member team of specialized engineers and technicians, delivered 100,000 flight-critical aeroengine components and precision tools meeting AS9100 standards, and secured USD100 million in long-term contracts with global aerospace companies, IndiGo Ventures said.
"By combining our technical expertise and global footprint, this partnership (with Jeh Aerospace) will propel use of next-generation technology in the aerospace and aviation sector. This investment also strengthens the Indo-US aerospace ties, advances make-in-India and accelerates innovation, contributing to realising India's potential to become a global aerospace and aviation hub," Pieter Elbers, Chief Executive Officer at IndiGo.
Despite India being one of the world's fastest-growing aviation markets, the country is still a small player in the global aerospace manufacturing industry, highlighting a significant gap in domestic manufacturing capacity, it stated.
"At Jeh Aerospace, we are forging a future-ready aerospace ecosystem by leveraging India's exceptional talent, advanced manufacturing, and AI-driven digital platforms. This investment empowers us to scale production capacity to meet growing demand from our global customers, ensuring flawless, on-time delivery of high-precision components," said Vishal R. Sanghavi, Co-founder and CEO, Jeh Aerospace.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
11 minutes ago
- India.com
India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister
New Delhi: Various schemes being implemented by the Centre to realise the vision of Aatmanirbhar Bharat in the pharmaceutical sector have resulted in India's exports of drugs and pharmaceuticals increasing by 92 per cent, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, the Parliament was informed on Friday. The schemes include the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, the PLI Scheme for Bulk Drugs, Scheme for Promotion of Bulk Drug Parks, and Strengthening of Pharmaceutical Industry scheme, Minister of State for Chemicals and Fertilisers Anupriya Patel told the Lok Sabha in a written reply to a question. The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India's Pharma MedTech sector from cost- to innovation-based growth by strengthening research and promoting industry-academia linkage for research and development in priority areas in drug discovery and development and medical devices. Under this scheme, seven Centres of Excellence (CoEs) have been set up, she said. The PLI Scheme for Pharmaceuticals aims to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high-value goods in the pharmaceutical sector. The minister said that the scheme has enabled enhanced investment and production in eligible products. As of March 2025, the committed investment of Rs 17,275 crore targeted over the six-year period of the scheme stands substantially exceeded with a cumulative investment of Rs 37,306 crore made by the scheme's third year, and cumulative sales of approved products of Rs 2,66,528 crore have been made, including exports of Rs 1,70,807 crore. The PLI Scheme for Bulk Drugs, which has a total budgetary outlay of Rs 6,940 crore, aims to avoid disruption in the supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs for which there are no alternatives by reducing supply disruption risk due to excessive dependence on a single source. As of March 2025, the committed investment of Rs 3,938.5 crore under projects approved under the scheme for investment over the six-year production period of the scheme stands substantially exceeded with a cumulative investment of Rs 4,570 crore made by the scheme's third year, she further stated. The minister also highlighted that the government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to make quality generic medicines available at affordable prices to all. Under the scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to provide medicines at prices that are about 50 per cent to 80 per cent lower than those of leading branded medicines in the market. Till June 6, 2025, a total of 16,912 JAKs have been opened, and on average, about 10 to 12 lakh persons visit these Kendras daily and avail of quality medicines at affordable prices. As many as 2,110 medicines and 315 surgicals, medical consumables and devices are under the scheme product basket, covering all major therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-allergic and gastro-intestinal medicines and nutraceuticals. As a result of the scheme, in the last 11 years, estimated savings of about Rs 38,000 crore have accrued to citizens in comparison to the prices of branded medicines. Further, the scheme has provided self-employment to over 16,000 persons, including over 6,800 women entrepreneurs, the minister added.
Time of India
11 minutes ago
- Time of India
Scrapped batteries could power India's lithium boom
Gujarat is set to give the ' Atmanirbhar Bharat ' mission a significant push in lithium - the 'white gold' indispensable for powering gadgets and e-vehicles - while also extracting the metal without polluting the environment. Scientists at the Bhavnagar-based Central Salt and Marine Chemicals Research Institute (CSMCRI) developed a clean, fast, and selective method to extract lithium from disposed batteries. This discovery could significantly reduce India's import bills as the country imports 100% of its lithium requirement. This study was recently published in Angewandte Chemie International Edition, a leading peer reviewed chemistry journal by the German Chemical Society. Scientists say the technology will give momentum to India's shift to green energy. On average, one ton of lithium requires processing about 28 tons of battery waste. The metal is recovered only after several stages of processes that are slow, inefficient, and costly, often resulting in metal contamination and loss, and the purity is also not high. This also deters battery producers from extracting lithium from waste. The conventional process, after recovering the black powder, first involves leaching all metals like nickel, cobalt, and manganese in the battery's cathode, resulting in significant loss and contamination. If scaled up after commercial application, businesses handling waste batteries could get a big encouragement and better price. At present, waste battery handling is not a lucrative business due to pollution and the small quantity of lithium obtained. CSMCRI's scientists have turned the problem on its head. Instead of lithium coming out last, their new method pulls lithium out first-with purity. After recovering the black powder from used lithium-ion batteries, anthraquinone salt and hydrogen peroxide are applied to selectively extract lithium. Kannan Srinivasan, director of CSIR-CSMCRI, said, "This method avoids the harsh chemicals and high-energy use of existing processes." Lead researcher and Principal Scientist Alok Ranjan Paital said, "We achieved 97% lithium leaching efficiency in just one hour. Also, compared to 2-3 days required by traditional methods to extract one ton of lithium, this new technique delivers the same results in just 2-3 hours with higher purity."
News18
18 minutes ago
- News18
Hyundai India Gets Rs 517.34 Cr Tax With Penalty Demand From GST Authority, Here's Why
Last Updated: The company said there is no impact on its financial, operational or other activities due to the order and is reviewing the order and will exercise the right to file an appeal. Hyundai Motor India Ltd on Tuesday said it has received a demand of Rs 517.34 crore from tax authorities, along with penalty, for alleged short payment of GST compensation cess on its certain SUV models. The company has received an order from Commissioner (Appeals), CGST Dept, Tamil Nadu, confirming GST compensation cess demand of Rs 258.67 crore, along with penalty of Rs 258.67 crore, on the allegation of short payment of GST compensation cess on certain SUV models for the period September 2017 – March 2020, Hyundai Motor India Ltd said in a regulatory filing. Reacting to the demand, a company spokesperson said, 'HMIL is of the view that the amendment and the clarifications given by the Central Board of Indirect Tax and Customs (CBIC) to resolve the issue faced by the industry on this matter are in favour of the company. We are in the process of reviewing the order and will exercise the right to seek a legal remedy through an appropriate forum." The company asserted that there is no impact on its financial, operational or other activities due to the order and is reviewing the order and will exercise the right to file an appeal. . view comments First Published: July 26, 2025, 08:17 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
